By rray, 26 March, 2024 Detail (Long) <b>If low thromboembolic risk</b> (AF w/ CHA<sub>2</sub>DS<sub>2</sub>-VASc <2-3, provoked VTE >3mo prior, bioprosthetic valve w/o AF >3mo ago), discontinuing OAC is reasonable.
